Fallarino F - Search Results

1

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.

Orabona C, Pallotta MT, Volpi C, Fallarino F, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Grohmann U, Puccetti P. Orabona C, et al. Among authors: fallarino f. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20828-33. doi: 10.1073/pnas.0810278105. Epub 2008 Dec 16. Proc Natl Acad Sci U S A. 2008. PMID: 19088199 Free PMC article.

2

CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.

Grohmann U, Bianchi R, Fioretti MC, Fallarino F, Binaglia L, Uyttenhove C, Van Pel A, Boon T, Puccetti P. Grohmann U, et al. Among authors: fallarino f. Eur J Immunol. 1995 Oct;25(10):2797-802. doi: 10.1002/eji.1830251013. Eur J Immunol. 1995. PMID: 7589074

3

[3H]aniracetam binds to specific recognition sites in brain membranes.

Fallarino F, Genazzani AA, Silla S, L'Episcopo MR, Camici O, Corazzi L, Nicoletti F, Fioretti MC. Fallarino F, et al. J Neurochem. 1995 Aug;65(2):912-8. doi: 10.1046/j.1471-4159.1995.65020912.x. J Neurochem. 1995. PMID: 7616253

4

Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.

Grohmann U, Puccetti P, Belladonna ML, Fallarino F, Bianchi R, Binaglia L, Sagakuchi K, Mage MG, Appella E, Fioretti MC. Grohmann U, et al. Among authors: fallarino f. J Immunol. 1995 May 1;154(9):4630-41. J Immunol. 1995. PMID: 7722315

5

IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.

Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P. Bianchi R, et al. Among authors: fallarino f. J Immunol. 1996 Aug 15;157(4):1589-97. J Immunol. 1996. PMID: 8759743

6

IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.

Grohmann U, Bianchi R, Belladonna ML, Silla S, Fallarino F, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2000 Aug 1;165(3):1357-63. doi: 10.4049/jimmunol.165.3.1357. J Immunol. 2000. PMID: 10903738

7

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.

Fallarino F, Grohmann U, Bianchi R, Vacca C, Fioretti MC, Puccetti P. Fallarino F, et al. J Immunol. 2000 Nov 15;165(10):5495-501. doi: 10.4049/jimmunol.165.10.5495. J Immunol. 2000. PMID: 11067902

8

CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.

Grohmann U, Fallarino F, Silla S, Bianchi R, Belladonna ML, Vacca C, Micheletti A, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2001 Jan 1;166(1):277-83. doi: 10.4049/jimmunol.166.1.277. J Immunol. 2001. PMID: 11123303

9

Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma.

Grohmann U, Belladonna ML, Vacca C, Bianchi R, Fallarino F, Orabona C, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2001 Jul 1;167(1):221-7. doi: 10.4049/jimmunol.167.1.221. J Immunol. 2001. PMID: 11418652

10

IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.

Grohmann U, Fallarino F, Bianchi R, Belladonna ML, Vacca C, Orabona C, Uyttenhove C, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2001 Jul 15;167(2):708-14. doi: 10.4049/jimmunol.167.2.708. J Immunol. 2001. PMID: 11441074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters